CompoAtlas

DOLIPHAR

Food supplement declared in France, declaration No 2020-5-262

DOLIPHAR is a food supplement declared in France. Status: retrait du marché annoncé pour le 25 June 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SAS Prophar
Status
Retrait du marché annoncé pour le 25 June 2027
Form
Gélule
Daily dose
4 gélules
Directions for use
2 à 3 gélules par jour. Jusqu'à 4 gélules en aigu
Not recommended for (according to the manufacturer)
Sous anticoagulants, Ulcère (estomac ou duodenum)

Declaration 275865, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum procumbensRacineExtrait sec aqueux640 mg
Boswellia serrata Roxb. ex Colebr.Gomme résineExtrait sec aqueux480 mg
Curcuma longa L.RhizomeExtrait sec alcoolique212 mg

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

L’emploi est déconseillé en cas d’ulcères (estomac ou duodénum) ou de calculs biliaires ainsi que chez les personnes sous traitement anticoagulant.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.